Biohit Oyj (0DRP) Financial Statements
Biohit Oyj Financial Overview
Biohit Oyj's market cap is currently $32.08M. The company's EPS TTM is $0.21; its P/E ratio is 10.27; Biohit Oyj is scheduled to report earnings on February 17, 2027, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 15.70M | $ 14.30M | $ 13.08M | $ 10.95M | $ 9.36M |
| Gross Profit | $ 6.10M | $ 9.30M | $ 8.46M | $ 7.11M | $ 5.91M |
| Operating Income | $ 3.20M | $ 2.60M | $ 1.82M | $ 1.13M | $ -1.48M |
| EBITDA | $ 3.70M | $ 3.50M | $ 2.69M | $ 1.61M | $ 693.00K |
| Net Income | $ 2.74M | $ 2.60M | $ 1.85M | $ 601.00K | $ -1.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.80M | $ 6.70M | $ 6.81M | $ 6.23M | $ 5.51M |
| Total Assets | $ 19.80M | $ 15.50M | $ 12.92M | $ 11.02M | $ 9.61M |
| Total Debt | $ 1.59M | $ 600.00K | $ 702.00K | $ 943.00K | $ 221.00K |
| Net Debt | $ -1.91M | $ -3.10M | $ -2.33M | $ -1.18M | $ -881.00K |
| Total Liabilities | $ 4.87M | $ 3.30M | $ 3.49M | $ 3.56M | $ 2.31M |
| Stockholders' Equity | $ 14.90M | $ 12.30M | $ 9.43M | $ 7.46M | $ 7.30M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.30M | $ 200.00K | $ 654.00K | $ 1.79M | $ -477.00K |
| Operating Cash Flow | $ -700.00K | $ 586.00K | $ 902.00K | $ 1.85M | $ -444.00K |
| Investing Cash Flow | $ 1.20M | $ 80.00K | $ 192.00K | $ -625.00K | $ 760.00K |
| Financing Cash Flow | $ -300.00K | $ -230.00K | $ -199.00K | $ -186.00K | $ -266.00K |
Currency in EUR